Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

TypeScript 7.0 became stable on July 8, 2026 — and for most of the tens of millions of professional web developers who depend on it daily, a single npm install -D typescript command now cuts build ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Vitalik Buterin has published an updated long-term roadmap for Ethereum, calling the multi-year effort “Lean Ethereum” as the network’s biggest redesign since the Merge. He posted it to X on July 4, ...

July 9, 2026 Oak trees keep absorbing carbon dioxide long after their annual growth has ended, revealing that photosynthesis and wood production are not as closely linked as scientists once believed.

Key Points Interested in Cerebras Systems Inc.? Here are five stocks we like better. Cerebras and OpenAI said their ...

The rise of AI has brought an avalanche of new terms and slang. Here is a glossary with definitions of some of the most ...